Mean female age at first birth has increased steadily over the past few decades in many developed countries. This postponement leads to couples attempting to have children during a period where female fertility may already be in decline.
Anti-Müllerian hormone (AMH)
AMH is a direct serum marker of functional ovarian reserve and plays an important role in assessing ovarian reserve levels and therefore the capacity to provide eggs for fertilisation.1,2
Serum AMH levels have been shown to remain relatively stable during the menstrual cycle and may be measured on any day of the cycle.1,2
AMH is a reliable marker for prediction of response to controlled ovarian stimulation and can therefore add prognostic information to the counselling and planning process for infertile couples seeking treatment.3
- Fully automated, fast, sensitive and robust measurement of AMH4
- High precision over entire measuring range for reliable results4,5
- Clinical agreement with Antral-Follicle-Count (AFC)6
- Age-specific reference ranges and polycystic ovary syndrome (PCOS) expected values5